1. Zheng, Ting, Zhang, Ding, Fu, Qingzhen, Liu, Jinyin, Zhao, Yashuang. 2024. DNA methylation-driven gene FAM3D promotes colorectal cancer growth via the ATF4-SESN2-mTORC1 pathway. In Aging, 16, 12866-12892. doi:10.18632/aging.206115. https://pubmed.ncbi.nlm.nih.gov/39388305/
2. Hu, Yuntao, Li, Jing, Li, Xin, Chi, Yujing, Yang, Jichun. 2023. Hepatocyte-secreted FAM3D ameliorates hepatic steatosis by activating FPR1-hnRNP U-GR-SCAD pathway to enhance lipid oxidation. In Metabolism: clinical and experimental, 146, 155661. doi:10.1016/j.metabol.2023.155661. https://pubmed.ncbi.nlm.nih.gov/37454871/
3. Peng, Xinjian, Xu, Enquan, Liang, Weiwei, Ma, Dalong, Wang, Ying. 2016. Identification of FAM3D as a new endogenous chemotaxis agonist for the formyl peptide receptors. In Journal of cell science, 129, 1831-42. doi:10.1242/jcs.183053. https://pubmed.ncbi.nlm.nih.gov/26966188/
4. Chen, Lizhu, Lin, Jie, Lan, Bin, Chen, Yu, Chen, Chuan-Ben. 2022. FAM3D as a Prognostic Indicator of Head and Neck Squamous Cell Carcinoma Is Associated with Immune Infiltration. In Computational and mathematical methods in medicine, 2022, 5851755. doi:10.1155/2022/5851755. https://pubmed.ncbi.nlm.nih.gov/36510584/